Data for (Study ST003920)
(Analysis AN006436)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study| Metabolite | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 | F11 | F12 | F13 | F14 | F15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D9-gammabutyrobetaine | 0.6501 | 4.6072 | NA | NA | NA | NA | 0.1208 | 0.0696 | NA | NA | NA | NA | NA | NA | NA |
| D9-hydroxytrimethyllysine | NA | NA | NA | NA | NA | NA | 1.3237 | 0.6763 | NA | NA | NA | NA | NA | NA | NA |
| D9-L-carnitine | NA | NA | NA | NA | NA | NA | 1.3158 | 0.6448 | NA | NA | NA | NA | NA | NA | NA |
| D9-Trimethyllysine | 2.9343 | 2.1331 | 1.0555 | 1.6483 | 0.5691 | 0.8588 | NA | NA | 0.2381 | 0.7994 | NA | NA | NA | NA | NA |
| Dimethylarginine | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 0.6462 | NA | 1.3538 | NA | NA |
| gamma-butyrobetaine | 1.1425 | 1.9643 | NA | NA | NA | NA | NA | NA | NA | NA | NA | 0.5557 | NA | 0.3375 | NA |
| L-carnitine | NA | NA | 0.0679 | 1.4236 | NA | NA | NA | NA | 0.1490 | 0.4686 | NA | 1.9899 | NA | 1.5229 | NA |
| L-gulonolactone | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 1.2392 | NA | 0.7608 | NA | NA |
| L-lysine | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 1.2175 | 0.1654 | 1.9331 | 0.2238 | NA |
| L-tryptophan | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 0.7727 | NA | 1.2273 | NA | NA |
| Methionine | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 0.7967 | NA | 1.2033 | NA | NA |
| oxoglutarate | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 1.4071 | NA | 0.5929 | NA | NA |
| Trimethyllysine | 0.0922 | 0.0607 | NA | NA | NA | NA | NA | NA | NA | NA | 1.4442 | 0.2288 | 2.8835 | 0.3596 | NA |
Factors:
| F1 | Sample source:293 cells | Sample type:293 cells | Genotype:Control | Treatment:10 uM D9-TML |
| F2 | Sample source:293 cells | Sample type:293 cells | Genotype:Overexpression | Treatment:10 uM D9-TML |
| F3 | Sample source:293 Mito | Sample type:293 Mito | Genotype:KO | Treatment:10 uM D9-TML |
| F4 | Sample source:293 Mito | Sample type:293 Mito | Genotype:Rescue | Treatment:10 uM D9-TML |
| F5 | Sample source:Ecoli | Sample type:Ecoli | Genotype:Control | Treatment:10 uM D9-TML |
| F6 | Sample source:Ecoli | Sample type:Ecoli | Genotype:Overexpression | Treatment:10 uM D9-TML |
| F7 | Sample source:Hepatocytes | Sample type:Hepatocytes | Genotype:Control | Treatment:10 uM D9-TML |
| F8 | Sample source:Hepatocytes | Sample type:Hepatocytes | Genotype:KO | Treatment:10 uM D9-TML |
| F9 | Sample source:Ing Mito | Sample type:Ing Mito | Genotype:Cre | Treatment:10 uM D9-TML |
| F10 | Sample source:Ing Mito | Sample type:Ing Mito | Genotype:Ctl | Treatment:10 uM D9-TML |
| F11 | Sample source:Serum | Sample type:Serum | Genotype:Control | Treatment:72h 6C |
| F12 | Sample source:Serum | Sample type:Serum | Genotype:Control | Treatment:None |
| F13 | Sample source:Serum | Sample type:Serum | Genotype:KO | Treatment:72h 6C |
| F14 | Sample source:Serum | Sample type:Serum | Genotype:KO | Treatment:None |
| F15 | Sample source:Serum | Sample type:Serum | Genotype:Slc25a45AlbKO | Treatment:72h 6C |
